ABL Bio Inc. (KOSDAQ:298380)

ABL Bio Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 29, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	7,547,110	11,025,033	1,443,630	1,178,156	1,099,129	1,041,424
Market Cap Growth	349.48%	663.70%	22.53%	7.19%	5.54%	-
Enterprise Value	7,489,470	10,941,258	1,335,337	1,126,398	1,038,936	-
Last Close Price	134800.00	200000.00	29900.00	24600.00	23000.00	22100.00
PE Ratio	-	-	-	-	342.55	-
PS Ratio	95.11	138.94	43.22	17.97	16.33	195.31
PB Ratio	48.16	70.36	8.63	15.90	15.81	18.61
P/TBV Ratio	49.70	72.60	8.91	16.47	16.43	19.50
P/FCF Ratio	-	-	-	-	15.69	-
P/OCF Ratio	-	-	-	-	15.24	-
EV/Sales Ratio	94.39	137.89	39.98	17.18	15.44	-
EV/EBITDA Ratio	-	-	-	-	321.37	-
EV/EBIT Ratio	-	-	-	-	1144.20	-
EV/FCF Ratio	-122.14	-	-	-	14.83	-
Debt / Equity Ratio	0.35	0.35	0.26	0.59	0.60	0.01
Debt / EBITDA Ratio	-	-	-	-	12.94	-
Debt / FCF Ratio	-	-	-	-	0.60	-
Net Debt / Equity Ratio	-0.38	-0.38	-0.58	-0.37	-0.52	-0.77
Net Debt / EBITDA Ratio	1.61	1.61	1.72	996.51	-11.28	0.88
Net Debt / FCF Ratio	0.97	0.97	1.25	0.80	-0.52	1.03
Asset Turnover	0.31	0.31	0.17	0.38	0.54	-
Quick Ratio	1.41	1.41	2.24	1.71	1.09	5.01
Current Ratio	1.43	1.43	2.28	1.81	1.12	5.20
Return on Equity (ROE)	-23.38%	-23.38%	-46.01%	-3.69%	5.12%	-
Return on Assets (ROA)	-9.84%	-9.84%	-18.93%	-0.95%	0.45%	-
Return on Capital Employed (ROCE)	-25.70%	-25.70%	-35.20%	-2.20%	0.80%	-90.30%
Earnings Yield	-0.50%	-0.34%	-3.85%	-0.22%	0.29%	-4.18%
FCF Yield	-0.81%	-0.56%	-5.43%	-2.90%	6.38%	-4.02%
Buyback Yield / Dilution	-7.25%	-7.25%	-0.37%	-0.58%	-1.27%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.